Auro Laboratories Ratios

Auro Laboratories Ltd Ratios

The Auro Laboratories Ltd Ratios page provides a complete fundamental analysis of Auro Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Auro Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Auro Laboratories Ltd (NSE: , BSE: 530233) is currently trading at ₹279.95, with a market capitalization of ₹0. As a major player in the Health technology sector and Pharmaceuticals: major industry, Auro Laboratories Ltd remains a key stock for fundamental analysis using Auro Laboratories Ltd Ratios.

Auro Laboratories Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Auro Laboratories Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Auro Laboratories Ltd Ratios.

Historically, the Auro Laboratories Ltd P/E ratio has shown strong fluctuations:

The decline in Auro Laboratories Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Auro Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Auro Laboratories Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Auro Laboratories Ltd P/S ratio currently stands at 0, an important part of Auro Laboratories Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Auro Laboratories Ltd P/S ratio indicates cautious market sentiment.

Auro Laboratories Ltd Price to Cash Flow Ratio (P/CF)

The Auro Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Auro Laboratories Ltd Price to Cash Flow Ratio:

The declining Auro Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Auro Laboratories Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Auro Laboratories Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Auro Laboratories Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Auro Laboratories Ltd EV/EBITDA ratio is currently 0, a key metric in Auro Laboratories Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Auro Laboratories Ltd EV/EBITDA indicates balanced valuation.

Auro Laboratories Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Auro Laboratories Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Auro Laboratories Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Auro Laboratories Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Auro Laboratories Ltd Ratios Analysis Summary

The Auro Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Auro Laboratories Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Auro Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.